AI Archives · BioBuzz

Loading …

BioTalk Podcast w/ 20/20 Gene Systems CEO Johnathan Cohen

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2018/05/Biotalk-Jcohen-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2018/05/Biotalk-Jcohen-100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2018/05/Biotalk-Jcohen-150x150.jpg 150w" data-src="https://biobuzz.io/wp-content/uploads/2018/05/Biotalk-Jcohen-300x300.jpg" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2018/05/Biotalk-Jcohen-300x300.jpg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2018/05/Biotalk-Jcohen-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2018/05/Biotalk-Jcohen-100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2018/05/Biotalk-Jcohen-150x150.jpg 150w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : May 17, 2018September 26, 2020 Published by : Chris Frew

Johnathan Cohen., Founder, and Chief Executive Officer, 20/20 GeneSystems Inc. joins Rich Bendis to discuss cancer diagnostics, crowdfunding, and where his company is headed. Under Mr. Cohen’s leadership, 20/20 GeneSystems [….]